GlassScriptPhysician profile
Yaron E Shalomoff
NPI 1427188598
$2,427.92
in general payments reported to CMS, 2019-2025
20 companies · $264 in 2025
The $264 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $554 · 2022: $775 · 2023: $469 · 2024: $366 · 2025: $264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,000 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $999.71 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $366.53 | 2021-2025 | |
| Pfizer INC. | $317.48 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $280.42 | 2021-2023 | Jardiance |
| Amgen INC. | $264.53 | 2021-2025 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $212.80 | 2021-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $151.15 | 2021-2024 | Xarelto |
| Medtronic, INC. | $124.56 | 2022-2024 | Selectsecure, Micra |
| Abbott Laboratories | $120.53 | 2024 | Cardiomems |
| Lilly USA, LLC | $116.04 | 2024 | Jardiance |
| Astellas Pharma US INC | $99.00 | 2023 | |
| Merck Sharp & Dohme LLC | $85.28 | 2021-2022 | |
| Novo Nordisk INC | $59.61 | 2022-2024 | Rybelsus, Ozempic |
| Abbvie INC. | $54.14 | 2021-2022 | |
| Amarin Pharma, INC. | $42.92 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $39.56 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bridgebio Pharma, INC. | $23.12 | 2025 | Attruby |
| Althera Pharmaceuticals LLC | $18.56 | 2021 | |
| Esperion Therapeutics, INC. | $18.00 | 2021 | |
| Boston Scientific Corporation | $17.27 | 2023 | Bodyguardian |
| Medicomp INC | $16.42 | 2023 | Telepatch Cardiac Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yaron Shalomoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.